Apricus Biosciences (APRI) Reports Q3 Loss of $0.19

November 8, 2016 4:40 PM EST
Get Alerts APRI Hot Sheet
Trade APRI Now!
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Apricus Biosciences (NASDAQ: APRI) reported Q3 EPS of ($0.19), versus ($1.00) reported last year. Revenue for the quarter came in at $4.3 million, versus $1.3 million reported last year.

For earnings history and earnings-related data on Apricus Biosciences (APRI) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment